Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...

The launch marked Danish drugmaker Novo Nordisk's debut on the continent, ramping up competition with rival Eli Lilly.

Johannesberg: Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its ...

By Nqobile Dludla and Siyanda Mthethwa JOHANNESBURG (Reuters) -Danish drugmaker Novo Nordisk introduced its weight-loss drug ...

Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa, marking its debut in Africa and ...

Celeste Ntuli opened up on her battle with obesity. The star's comments comes as Mzansi is discussing the new looks of celebs ...

In South Africa, these medicines remain largely inaccessible given their high costs, despite the large public health need for effective treatments for diabetes and obesity. For the few that can afford ...

Danish drug maker Novo Nordisk introduced its weight-loss drug Wegovy in SA on Thursday, marking its debut in Africa and stepping up competition with Eli Lilly’s Mounjaro which ...

The approval is based on a 17,000-patient study that showed that people taking Wegovy, the sister drug to the better-known Ozempic, had a 20% lower risk of a cardiac event than those taking a placebo.

T he obesity drug Wegovy can now claim to lower the risk of heart attack, stroke, and other cardiovascular issues in people who are overweight or who have obesity, and also have cardiovascular ...

Ozempic and Wegovy may not be right for you if you have certain medical conditions or other factors that affect your health. The two drugs share some of the same precautions, but they also have ...